Bio & Pharma
S.Korea’s top pharmaceutical distributor buys 25% of No. 2 Baekje Pharma
Getting approval from the Fair Trade Commission, Geo-young expects synergy between customer expansion and export promotion
By Jun 14, 2023 (Gmt+09:00)
1
Min read
Most Read
Samsung steps up AR race with advanced microdisplay for smart glasses


When in S. Korea, it’s a ritual: Foreigners make stops at CU, GS25, 7-Eleven


Maybe Happy Ending: A robot love story that rewrote Broadway playbook


NPS yet to schedule external manager selection; PE firms’ fundraising woes deepen


US auto parts tariffs take effect; Korea avoids heavy hit



South Korea’s top pharmaceutical distributor Geo-young Co. has acquired 25% of market No. 2 Baekje Pharmaceutical.
Geo-young on Tuesday said the Fair Trade Commission approved the transaction. Founded in 2002, the company has 80% of domestic pharmacies as customers and tops its sector in sales.
The stake purchase is in line with the aggressive overseas advance of the nation’s healthcare industry by promoting exports of domestic medicine and medical devices.
“Geo-young and Baekje Pharmaceutical will create business synergy by using each other’s strengths,” a Geo-young source said. “This collaboration will be an important inflection point for raising the competitiveness of domestic pharmaceutical distribution overall and advancing its business.”
Write to Ji-Hyun Lee at bluesky@hankyung.com
More to Read
-
Electric vehiclesBYD’s Atto 3 overtakes Tesla’s Model Y as best-selling EV in South Korea
2 HOURS AGO
-
-
Corporate investmentLG Electronics breaks ground on $600 mn home appliance plant in India
20 HOURS AGO
-
EarningsKakaoBank posts record Q1 profit, eyes Thai expansion after Indonesia
May 08, 2025 (Gmt+09:00)
-
E-commerceCoupang’s Q1 revenue up; quarterly dip signals rising competition
May 07, 2025 (Gmt+09:00)
Comment 0
LOG IN